Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Toll Brothers Wins Multiple Awards for Colorado Springs Parade of Homes
-
MSC CRUISES SERVES AS TITLE SPONSOR FOR AUSTIN 2025 GRAND PRIX™, ANNOUNCES CONTINUED PARTNERSHIP WITH FORMULA 1® FOR 2026 SEASON
-
Epiminder Announces Appointment of Mark McLellan as Chief Financial Officer
-
Benchmark Electronics to Report Third Quarter Fiscal Year 2025 Results
-
Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform
-
Provident Financial Holdings, Inc. To Host Earnings Release Conference Call
-
Teekay Group to Announce Third Quarter 2025 Earnings Results on October 29, 2025
-
Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2025 Earnings Release and Conference Call Date
-
Adamas Trust 2025 Third Quarter Conference Call Scheduled for Thursday, October 30, 2025
-
Chemung Financial Corporation Reports Third Quarter 2025 Net Income of $7.8 million, or $1.62 per share
-
Capital One Reports Third Quarter 2025 Net Income of $3.2 billion, or $4.83 per share
-
Orrstown Financial Services, Inc. Reports Third Quarter 2025 Results
-
Hanmi Reports 2025 Third Quarter Results
-
Reed’s Schedules Third Quarter 2025 Conference Call for November 4 at 8:30 a.m. ET
-
Postal Realty Trust, Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Vicor Corporation Reports Results for the Third Quarter Ended September 30, 2025
-
Mattel Reports Third Quarter 2025 Financial Results
-
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
-
AST SpaceMobile Announces Proposed Private Offering of $850.0 Million of Convertible Senior Notes Due 2036
-
Agree Realty Corporation Reports Third Quarter 2025 Results
-
Pega Unlocks AI Potential in Q3 2025
-
Solo Brands, Inc. Fiscal 2025 Third Quarter Financial Results To Be Released Thursday, November 6, 2025
-
Manhattan Associates Reports Third Quarter Results
-
Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
Jamieson Wellness Inc. Announces Appointment of New Board Director
-
LifeVantage to Announce First Quarter Fiscal Year 2026 Results on November 4, 2025
-
East West Bancorp Reports Record Quarterly Net Income of $368 Million and Diluted Earnings Per Share of $2.65; Record Fees, Loans, and Deposits
-
Meta Announces Joint Venture with Funds Managed by Blue Owl Capital to Develop Hyperion Data Center
-
NOG Provides Third Quarter Update
-
Manhattan Associates Announces Appointment of Greg Betz as Chief Operating Officer
-
AST SpaceMobile Announces Proposed Repurchase of up to $50.0 Million Convertible Senior Notes to be Funded By Concurrent Registered Direct Offering of Class A Common Stock
-
Ramaco Resources, Inc. to Release Third Quarter 2025 Financial Results on Monday, October 27, 2025 and Host Conference Call and Webcast on Tuesday, October 28, 2025
-
P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
-
New Jersey American Water and Gordon’s Corner Water Company Reach Acquisition Agreement
-
Sherwin-Williams Declares Dividend of $0.79 per Common Share
-
Onto Innovation to Report Third Quarter 2025 Financial Results on November 6, 2025
-
Finance of America Announces Third Quarter Earnings Release and Conference Call on November 4, 2025
-
Rocky Brands, Inc. to Report Third Quarter 2025 Results on October 28, 2025
-
Magnachip to Announce Third Quarter 2025 Financial Results on November 3, 2025
-
Toast Announces Release Date of Third Quarter 2025 Financial Results
-
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
-
Coupang to Announce Third Quarter 2025 Results on November 4, 2025
-
Getty Realty Corp. Announces Increased Quarterly Cash Dividend
-
Inspired to Report Third Quarter 2025 Results and Hold Conference Call on November 5
-
Bitfarms Announces Closing of US$500 Million of Convertible Senior Notes
-
MARA Schedules Conference Call for Third Quarter 2025 Financial Results
-
Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity
-
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
-
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update
